Understanding value drivers of a gene therapy (GTx) in Duchenne Muscular Dystrophy (DMD)

Our client sought to test target product profiles (TPPs) with neurologists to deepen their understanding of customer expectations towards GTx, opportunities for differentiation, and  content channel preferences.

CRA approach

  • Developed market research materials (DG & Stimuli) in alignment with the client
  • Conducted in-depth interviews with DMD treaters
  • Analyzed and synthesized data from qualitative interviews into meaningful insights
  • Generated forecast assumptions to support commercial planning

Client impact

  • Advised on product’s differentiation factors and preferred information channels for a better uptake of the GTx at launch
  • Informed about potential barriers to gain market share
  • Provided insights to inform client’s forecast based on interviewees’ prescription intentions
Related capabilities